Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

RSV booster study aims to keep seniors safe

NCT ID NCT07117487

First seen Feb 02, 2026 · Last updated Apr 30, 2026 · Updated 18 times

Summary

This study tests a new mRNA booster shot (mRNA-1345) for RSV in adults aged 60 and older who received a prior RSV vaccine at least one year ago. Researchers will check for side effects and measure how well the booster strengthens the immune system. The goal is to see if revaccination is safe and effective for ongoing protection.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RESPIRATORY SYNCYTIAL VIRUS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Indago Research & Health Center, Inc.

    Hialeah, Florida, 33012, United States

  • Velocity Clinical Research, Austin

    Austin, Texas, 78759, United States

  • Velocity Clinical Research, Covington

    Covington, Louisiana, 70433, United States

  • Velocity Clinical Research, Denver

    Denver, Colorado, 80110, United States

  • Velocity Clinical Research, Hampton

    Hampton, Virginia, 23666, United States

  • Velocity Clinical Research, Lincoln

    Lincoln, Nebraska, 68510, United States

  • Velocity Clinical Research, Medford

    Medford, Oregon, 97504, United States

  • Velocity Clinical Research, Rockville

    Rockville, Maryland, 20854, United States

  • Velocity Clinical Research, Savannah

    Savannah, Georgia, 31406, United States

  • Velocity Clinical Research, Spokane

    Spokane, Washington, 99218, United States

  • Velocity Clinical Research, Valparaiso

    Valparaiso, Indiana, 46383, United States

Conditions

Explore the condition pages connected to this study.